Vericel Corp (VCEL) Financial Statements (2025 and earlier)

Company Profile

Business Address 64 SIDNEY ST.
CAMBRIDGE, MA 02139
State of Incorp. MI
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments112,902116,213101,734102,508110,648109,557
Cash and cash equivalent73,49074,52053,68150,29162,93869,088
Short-term investments39,41241,69348,05352,21747,71040,469
Restricted cash and investments 6,21510,52916,66925,5637,80417,778
Receivables47,79955,97543,67942,59644,63452,756
Inventory, net of allowances, customer advances and progress billings17,10617,37315,75614,88713,55713,087
Inventory17,10617,37315,75614,88713,55713,087
Other current assets8,5187,2877,8826,4327,7756,853
Other undisclosed current assets5,1005,4004,8005,4005,3005,600
Total current assets:197,640212,777190,520197,386189,718205,631
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization686686    
Operating lease, right-of-use asset68,71670,09871,56173,02073,68273,462
Long-term investments and receivables43,34239,88032,89526,12029,43325,283
Long-term investments43,34239,88032,89526,12029,43325,283
Intangible assets, net (including goodwill)6,0946,2506,4066,5636,7196,875
Intangible assets, net (excluding goodwill)6,0946,2506,4066,5636,7196,875
Restricted cash and investments 6,21510,52916,66925,5637,80417,778
Other noncurrent assets501556610664717771
Other undisclosed noncurrent assets101,39391,94671,74447,52348,58823,857
Total noncurrent assets:226,947219,945199,885179,453166,943148,026
TOTAL ASSETS:424,587432,722390,405376,839356,661353,657
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,16940,91335,22738,07230,45839,562
Accounts payable16,75123,84820,88425,21619,43222,347
Accrued liabilities11,41817,06514,34312,85611,02617,215
Debt116116    
Other liabilities116116    
Other undisclosed current liabilities11,0479,1416,1195,7916,0126,187
Total current liabilities:39,44850,28641,34643,86336,47045,749
Noncurrent Liabilities
Liabilities, other than long-term debt89,65290,46991,58789,99986,29581,956
Other liabilities1,848876243198154100
Operating lease, liability87,80489,59391,34489,80186,14181,856
Total noncurrent liabilities:89,65290,46991,58789,99986,29581,956
Total liabilities:129,100140,755132,933133,862122,765127,705
Equity
Equity, attributable to parent295,487291,967257,472242,977233,896225,952
Common stock699,412684,778669,735654,971641,180629,229
Accumulated other comprehensive income (loss)1364359(273)(245)(100)
Accumulated deficit(404,061)(392,815)(412,622)(411,721)(407,039)(403,177)
Total equity:295,487291,967257,472242,977233,896225,952
TOTAL LIABILITIES AND EQUITY:424,587432,722390,405376,839356,661353,657

Income Statement (P&L) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Revenues52,59875,37657,90552,66251,28164,996
Cost of revenue
(Cost of Product and Service Sold)
(16,325)(16,877)(16,252)(16,061)(15,927)(16,489)
Gross profit:36,27358,49941,65336,60135,35448,507
Operating expenses(49,065)(40,020)(44,118)(42,632)(40,818)(35,776)
Operating income (loss):(12,792)18,479(2,465)(6,031)(5,464)12,731
Nonoperating income1,5461,4761,5641,3491,6021,362
Investment income, nonoperating1,6571,5601,5781,5101,7621,436
Interest and debt expense(153)(154)(154)(153)(153)(156)
Income (loss) from continuing operations before equity method investments, income taxes:(11,399)19,801(1,055)(4,835)(4,015)13,937
Other undisclosed income from continuing operations before income taxes  154154  156
Income (loss) from continuing operations before income taxes:(11,399)19,955(901)(4,835)(4,015)14,093
Income tax expense      (1,100)
Other undisclosed loss from continuing operations  (148)    
Net income (loss):(11,399)19,807(901)(4,835)(4,015)12,993
Other undisclosed net income attributable to parent153  153153 
Net income (loss) available to common stockholders, diluted:(11,246)19,807(901)(4,682)(3,862)12,993

Comprehensive Income ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Net income (loss):(11,399)19,807(901)(4,835)(4,015)12,993
Comprehensive income (loss):(11,399)19,807(901)(4,835)(4,015)12,993
Other undisclosed comprehensive income (loss), net of tax, attributable to parent285(355)6321258363
Comprehensive income (loss), net of tax, attributable to parent:(11,114)19,452(269)(4,710)(4,007)13,356

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: